يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"SAE, Severe adverse effect"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1

    المصدر: Regenerative Therapy, Vol 11, Iss, Pp 143-166 (2019)
    Regenerative Therapy

    مصطلحات موضوعية: 0301 basic medicine, Ropinirole hydrochloride, ALP, Alkaline phosphatase, SOD, Superoxide dismutase, ALS, Amyotrophic lateral sclerosis, 0302 clinical medicine, HDL, High-density lipoprotein, Amyotrophic lateral sclerosis, APTT, Activated partial thromboplastin time, ADR, Adverse reaction, lcsh:R5-920, 6-OHDA, 6-hydroxydopamine, lcsh:Cytology, HBs, Hepatitis B surface, HTLV-1, Human T-cell leukemia virus type 1, MMT, Manual muscle testing, CPK, Creatine phosphokinase, GCP, Good clinical practice, Riluzole, %FVC, Forced vital capacity, HIV, Human immunodeficiency virus, Tolerability, CRP, C-reactive protein, Original Article, CTCAE, Common terminology Criteria for Adverse Events, AST, Aspartate aminotransferase, lcsh:Medicine (General), Requip CR, BUN, Blood urea nitrogen, medicine.drug, SALS, sporadic ALS, medicine.medical_specialty, FAS, Full analysis set, Randomization, EDC, Electronic data capture, TDP-43, Transactive response DNA-binding protein 43, TPHA, Treponema pallidum hemagglutination, Biomedical Engineering, IRB, Institutional review board, Placebo, HCV, Hepatitis C virus, Biomaterials, SAE, Severe adverse effect, 03 medical and health sciences, HCG, Human chorionic gonadotropin, 8-OHdG, 8-Hydroxydeoxyguanosine, NfL, Neurofilament light chain, Internal medicine, medicine, ALSFRS-R, ALS Functional Rating Scale-Revised, Ropinirole Hydrochloride, lcsh:QH573-671, ALSAQ-40, Amyotrophic Lateral Sclerosis Assessment Questionnaire-40, AE, Adverse effect, LDH, Lactate dehydrogenase, business.industry, PPS, Per protocol set, QOL, Quality of life, ALT, Alanine aminotransferase, CK, Creatine kinase, medicine.disease, Clinical trial, FALS, Familial ALS, PT, Prothrombin time, iPSC-drug discovery, CAFS, Combined Assessment of Function and Survival, 030104 developmental biology, LDL, Low-density lipoprotein, business, 030217 neurology & neurosurgery, Progressive disease, Developmental Biology

  2. 2
    دورية أكاديمية

    المؤلفون: Morimoto S; Department of Physiology, Keio University School of Medicine, Japan.; Department of Neurology, Keio University School of Medicine, Japan., Takahashi S; Department of Neurology, Keio University School of Medicine, Japan., Fukushima K; Department of Physiology, Keio University School of Medicine, Japan., Saya H; Division of Gene Regulation, Institute for Advanced Medical Research, Graduate School of Medicine, Keio University, Japan., Suzuki N; Department of Neurology, Keio University School of Medicine, Japan.; Department of Neurology, Shonan Keiiku Hospital, Japan., Aoki M; Department of Neurology, Tohoku University, School of Medicine, Japan., Okano H; Department of Physiology, Keio University School of Medicine, Japan., Nakahara J; Department of Neurology, Keio University School of Medicine, Japan.

    المصدر: Regenerative therapy [Regen Ther] 2019 Jul 26; Vol. 11, pp. 143-166. Date of Electronic Publication: 2019 Jul 26 (Print Publication: 2019).

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: The Japanese Society for Regenerative Medicine. Production and Hosting by Elsevier B.V Country of Publication: Netherlands NLM ID: 101709085 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-3204 (Electronic) Linking ISSN: 23523204 NLM ISO Abbreviation: Regen Ther Subsets: PubMed not MEDLINE